Catholic Universtiy of Korea. Seoul St Mary's Hospital
Seoul, 137-701, South Korea
NCT Number: NCT02428998
Korean Red Ginseng appears to adverse events in adults taking 24 weeks Placebo and comparative assessment. And exploratory as Korean Red Ginseng blood sugar control, reduce body fat, URTI prevention, cardiovascular risk, renal function, cholesterol, improve, fatigue, and determine the impact on biological age.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Seoul, 137-701, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks to collect all focus point after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Time frame: up to 24 weeks time after taking the Investigational product
Korea Ginseng Corporation
Industry
Safety Evaluation for 24 Weeks Intake of Korean Red Ginseng in Adults: A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center, Exploratory Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03543644
Body Weight, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT06675994
Body Weight, Cardiovascular Diseases
View Trial DetailsNCT05563090
Cardiovascular Diseases, Diabete Mellitus
Singapore
View Trial DetailsNCT00001963
Aneurysm, Behavior
Bethesda, Maryland, United States
View Trial Details